Table 2 Demographics and frequencies of ocular and systemic comorbidities. Data presented in Median (IQR) unless specified otherwise
From: Cataract risk stratification and prioritisation protocol in the COVID-19 era
Demographics | Results |
|---|---|
Sex (% Females) | 393 (55.4) |
Ethnicity (% Whites) | 628 (98.4) |
Age | 76 (69 to 82) |
Waiting List Duration in weeks | 6.8 (3.9 to 9.6) |
Ocular Comorbidities | n (%) |
Moderate to severe AMD | 31 (4.7) |
Amblyopia | 11 (1.7) |
Cornea opacification | 6 (0.9) |
Retinal artery/vein occlusion | 6 (0.9) |
Chronic retinal degeneration | 4 (0.6) |
Central visual impairment | 4 (0.6) |
Optic neuropathy | 2 (0.3) |
Active uveitis | 1 (0.2) |
Other maculopathy (excluding AMD) | 10 (1.5) |
Systemic Comorbidities | |
Chronic heart disease | 194 (28.9) |
Diabetes | 148 (22.1) |
Chronic kidney disease | 139 (20.7) |
Chronic respiratory disease | 66 (9.9) |
Malignancy | 39 (5.8) |
Others | 458 (68.3) |